ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
The metabolism of triglyceride-rich lipoproteins is impaired in patients with obstructive sleep apnoea: effects of treatment with continuous positive airway pressure (2017)
Drager, Luciano Ferreira; Silva, V. M; Tavoni, Thauany Martins; Santos, R. D; Pedrosa, Rodrigo Pinto; Bortolotto, Luiz Aparecido; Vinagre, Carmen Guilherme Christiano de Matos; Polotsky, Vsevolod Y; Lorenzi Filho, Geraldo; Maranhão, Raul Cavalcante
Fonte: European Heart Journal. Nome do evento: European Society Cardiology Congress (ESC). Unidade: FCF
Assuntos: LIPOPROTEÍNAS, APNEIA DO SONO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira et al. The metabolism of triglyceride-rich lipoproteins is impaired in patients with obstructive sleep apnoea: effects of treatment with continuous positive airway pressure. European Heart Journal. Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 06 nov. 2024. , 2017
APA
Drager, L. F., Silva, V. M., Tavoni, T. M., Santos, R. D., Pedrosa, R. P., Bortolotto, L. A., et al. (2017). The metabolism of triglyceride-rich lipoproteins is impaired in patients with obstructive sleep apnoea: effects of treatment with continuous positive airway pressure. European Heart Journal. Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Drager LF, Silva VM, Tavoni TM, Santos RD, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. The metabolism of triglyceride-rich lipoproteins is impaired in patients with obstructive sleep apnoea: effects of treatment with continuous positive airway pressure. European Heart Journal. 2017 ; 38 1329 res. P6235.[citado 2024 nov. 06 ]
Vancouver
Drager LF, Silva VM, Tavoni TM, Santos RD, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. The metabolism of triglyceride-rich lipoproteins is impaired in patients with obstructive sleep apnoea: effects of treatment with continuous positive airway pressure. European Heart Journal. 2017 ; 38 1329 res. P6235.[citado 2024 nov. 06 ]
Trabalho de evento-resumo periodico
Regression of atherosclerosis plaques of cholesterol-fed rabbits by combined chemotherapy of paclitaxel and methotrexate carried in lipid core nanoparticles (2017)
Gomes, F. T. Torres; Maranhão, Raul Cavalcante ; Tavares, Elaine Rufo; Carvalho, Priscila Oliveira de; Mattos, F. R; Machado, T; Higuchi, Maria de Lourdes; Hatab, S. A; Kalil Filho, Roberto
Fonte: European Heart Journal. Nome do evento: European Society Cardiology Congress (ESC). Unidades: FCF, FM
Assuntos: ARTERIOSCLEROSE, NANOPARTÍCULAS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, F. T. Torres et al. Regression of atherosclerosis plaques of cholesterol-fed rabbits by combined chemotherapy of paclitaxel and methotrexate carried in lipid core nanoparticles. European Heart Journal. Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 06 nov. 2024. , 2017
APA
Gomes, F. T. T., Maranhão, R. C., Tavares, E. R., Carvalho, P. O. de, Mattos, F. R., Machado, T., et al. (2017). Regression of atherosclerosis plaques of cholesterol-fed rabbits by combined chemotherapy of paclitaxel and methotrexate carried in lipid core nanoparticles. European Heart Journal. Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Gomes FTT, Maranhão RC, Tavares ER, Carvalho PO de, Mattos FR, Machado T, Higuchi M de L, Hatab SA, Kalil Filho R. Regression of atherosclerosis plaques of cholesterol-fed rabbits by combined chemotherapy of paclitaxel and methotrexate carried in lipid core nanoparticles. European Heart Journal. 2017 ; 38 1070-1071 res. P5162.[citado 2024 nov. 06 ]
Vancouver
Gomes FTT, Maranhão RC, Tavares ER, Carvalho PO de, Mattos FR, Machado T, Higuchi M de L, Hatab SA, Kalil Filho R. Regression of atherosclerosis plaques of cholesterol-fed rabbits by combined chemotherapy of paclitaxel and methotrexate carried in lipid core nanoparticles. European Heart Journal. 2017 ; 38 1070-1071 res. P5162.[citado 2024 nov. 06 ]
Artigo de periodico
SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension (2017)
Galiè, Nazzareno; Jansa, Pavel; Pulido, Tomás; Channick Richard N.; Delcroix, Marion; Ghofrani, Hossein-Ardeschir; Le Brun, Franck-Olivier; Mehta, Sanjay; Perchenet, Loïc; Rubin Lewis J.; Sastry, B.K.S.; Simonneau, Gérald; Sitbon, Olivier; Souza, Rogério; Torbicki, Adam
Fonte: European Heart Journal. Unidade: FM
Assuntos: MORTALIDADE, CATETERISMO CARDÍACO, ESTUDOS RANDOMIZADOS, HIPERTENSÃO PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GALIÈ, Nazzareno et al. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. European Heart Journal, v. 38, n. 15, p. 1147-1155, 2017Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehx025. Acesso em: 06 nov. 2024.
APA
Galiè, N., Jansa, P., Pulido, T., Channick Richard N.,, Delcroix, M., Ghofrani, H. -A., et al. (2017). SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. European Heart Journal, 38( 15), 1147-1155. doi:10.1093/eurheartj/ehx025
NLM
Galiè N, Jansa P, Pulido T, Channick Richard N., Delcroix M, Ghofrani H-A, Le Brun F-O, Mehta S, Perchenet L, Rubin Lewis J., Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension [Internet]. European Heart Journal. 2017 ; 38( 15): 1147-1155.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1093/eurheartj/ehx025
Vancouver
Galiè N, Jansa P, Pulido T, Channick Richard N., Delcroix M, Ghofrani H-A, Le Brun F-O, Mehta S, Perchenet L, Rubin Lewis J., Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension [Internet]. European Heart Journal. 2017 ; 38( 15): 1147-1155.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1093/eurheartj/ehx025

Unidades USP

ReP

Filtros

Autores

Assuntos

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos